We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TTI:NYSETetra Technologies, Inc. Analysis

Data as of 2026-09-01 - not real-time

$6.90

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $6.90, TETRA Technologies, Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has lost 22.2% over the past 30 days. Relative strength is 32.7 — approaching oversold — and the MACD signal is bearish. The recent range runs from support at $6.69 up to resistance at $9.16.
The shares look fair, trading on 172.5 times earnings above a sector average of 21.6. Sell-side targets cluster 90.2% above the current quote. Revenue is growing at 6.8% on a 1.0% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 60.4%, a beta of 1.64 and a maximum drawdown of 45.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 1/10 conviction over the longer horizon.

Top Market Events

Strong sequential revenue growth and a pivotal investment in the Arkansas bromine project position Tetra for long-term...SPRING, Texas AP — SPRING, Texas AP — Tetra Technologies Inc.Although the revenue and EPS for Tetra Technologies TTI give a sense of how its business performed in the quarter ended...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 9.32
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 172.5 versus sector average of 21.6
  • Trading below the 200-day average of 9.32

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 172.5 versus sector average of 21.6
  • Analyst targets imply +90.2% versus the current price
  • 30-day volatility of 60.4%

Key Metrics & Analysis

Financial Health

Revenue Growth6.80%
Profit Margin0.97%
P/E Ratio172.5
ROE2.13%
ROA4.34%
Debt/Equity55.06
P/B Ratio2.5
Op. Cash Flow$70.6M
Free Cash Flow$1.4M
Industry P/E21.6

Technical Analysis

TrendBearish
RSI32.7
Support$6.69
Resistance$9.16
MA 20$7.84
MA 50$8.66
MA 200$9.32
MACDBearish
VolumeIncreasing
Fear & Greed Index94.43

Valuation

Target Price$13.13
Upside/Downside90.22%
GradeFair
TypeGrowth

Risk Assessment

Beta1.64
Volatility60.39%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.